Skip to content
Sora Lifesciences
European wound-care innovator

A go-to-market strategy for a wound-care innovator entering Sweden

Built an evidence-based market entry strategy for an advanced wound-management solution entering Sweden — sizing the opportunity, mapping regulatory and reimbursement requirements, and identifying the KOLs and distributors needed to launch.

Key offerings in this project
  • Market Landscape Assessment
  • Reimbursement Landscape & Data Analytics
  • Global KOL Identification & Profiling
  • Global Distributor Matchmaking

The brief

Build an evidence-based market entry strategy for advanced wound care entering Sweden

  • Size the Swedish opportunity
  • Map the regulatory and reimbursement requirements
  • Profile the high-value KOLs to engage
  • Identify and evaluate distributor candidates

The ambition to enter Sweden was already settled; the gap was practical, not strategic.

The problem

No clear read on the size of the opportunity, or on the practical steps entry would demand

  • Opportunity size unquantified
  • Regulatory and reimbursement path undefined
  • No stakeholder or distributor relationships in market
  • Launch workload at risk of being underestimated

Entering without a defined plan is where market-entry timelines usually slip.

Our approach

Secondary research across market, regulation and reimbursement, validated directly with practising surgeons

  • Market opportunity, regulation, reimbursement and competitive dynamics
  • Five-minute express surveys with surgeons
  • Treatment practices, unmet needs and adoption potential tested
  • KOLs profiled on publications, clinical trials and scientific influence

Distributors were mapped and scored on capability and strategic fit in parallel.

Key outcomes

A concrete, ready-to-execute engagement plan in place of a market-entry ambition

  • Quantified market opportunity assessment
  • Regulatory and reimbursement roadmap with real timelines
  • Curated KOL list for clinical engagement
  • Shortlisted, evaluated distributor candidates

Regulatory and reimbursement proved a genuine barrier to entry, not just paperwork.

Get in touch

Facing a similar challenge?

Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.

© 2026 Sora Life Sciences. All rights reserved.